Immediate Impact
1 from Science/Nature 68 standout
Citing Papers
Type 1 diabetes
2023 Standout
SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications
2021 Standout
Works of J.M. Ekoé being referenced
Safety and Efficacy of Dulaglutide, a Once Weekly GLP-1 Receptor Agonist, for the Management of Type 2 Diabetes
2014
Carbohydrate counting accuracy and blood glucose variability in adults with type 1 diabetes
2012
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| J.M. Ekoé | 240 | 44 | 138 | 108 | 13 | 417 | |
| P. Gatcomb | 283 | 39 | 108 | 46 | 11 | 495 | |
| James M. Cerletty | 219 | 81 | 156 | 59 | 19 | 466 | |
| Martha L. Spencer | 211 | 81 | 74 | 108 | 15 | 403 | |
| Larry Dolan | 211 | 52 | 255 | 139 | 14 | 502 | |
| G. M. Blake | 107 | 31 | 89 | 92 | 9 | 452 | |
| Vassiliki Syriou | 108 | 67 | 85 | 73 | 18 | 475 | |
| Anna Rita Maurizi | 133 | 86 | 65 | 60 | 19 | 390 | |
| Miho Senda | 203 | 66 | 81 | 47 | 17 | 461 | |
| Brian Heil | 94 | 21 | 302 | 53 | 12 | 424 | |
| Edita Jašinskienė | 187 | 43 | 140 | 135 | 11 | 390 |
All Works
Loading papers...